 <h1>HiDex Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>dexamethasone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about dexamethasone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name HiDex.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to dexamethasone: oral elixir, oral solution, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, dexamethasone (the active ingredient contained in HiDex) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking dexamethasone:</p><p>
<i>More common</i>
</p><ul>
<li>Aggression</li>
<li>agitation</li>
<li>anxiety</li>
<li>blurred vision</li>
<li>decrease in the amount of urine</li>
<li>dizziness</li>
<li>fast, slow, pounding, or irregular heartbeat or pulse</li>
<li>headache</li>
<li>irritability</li>
<li>mental depression</li>
<li>mood changes</li>
<li>nervousness</li>
<li>noisy, rattling breathing</li>
<li>numbness or tingling in the arms or legs</li>
<li>pounding in the ears</li>
<li>swelling of the fingers, hands, feet, or lower legs</li>
<li>trouble thinking, speaking, or walking</li>
<li>troubled breathing at rest</li>
<li>weight gain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach cramping and/or burning (severe) or pain</li>
<li>backache</li>
<li>bloody, black, or tarry stools</li>
<li>cough or hoarseness</li>
<li>darkening of the skin</li>
<li>decrease in height</li>
<li>decreased vision</li>
<li>diarrhea</li>
<li>dry mouth</li>
<li>eye pain</li>
<li>eye tearing</li>
<li>facial hair growth in females</li>
<li>fainting</li>
<li>fatigue</li>
<li>fever or chills</li>
<li>flushed, dry skin</li>
<li>fractures</li>
<li>fruit-like breath odor</li>
<li>full or round face, neck, or trunk</li>
<li>heartburn and/or indigestion (severe and continuous)</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>loss of appetite</li>
<li>loss of sexual desire or ability</li>
<li>lower back or side pain</li>
<li>menstrual irregularities</li>
<li>muscle pain or tenderness</li>
<li>muscle wasting or weakness</li>
<li>nausea</li>
<li>pain in the back, ribs, arms, or legs</li>
<li>painful or difficult urination</li>
<li>skin rash</li>
<li>sleeplessness</li>
<li>sweating</li>
<li>trouble healing</li>
<li>trouble sleeping</li>
<li>unexplained weight loss</li>
<li>unusual tiredness or weakness</li>
<li>vision changes</li>
<li>vomiting</li>
<li>vomiting of material that looks like coffee grounds</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of dexamethasone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Increased appetite</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abnormal fat deposits on the face, neck, and trunk</li>
<li>acne</li>
<li>dry scalp</li>
<li>lightening of normal skin color</li>
<li>red face</li>
<li>reddish purple lines on the arms, face, legs, trunk, or groin</li>
<li>swelling of the stomach area</li>
<li>thinning of the scalp hair</li>
</ul><p>
<!-- end oral elixir, oral solution, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dexamethasone: compounding powder, inhalation aerosol with adapter, injectable solution, injectable suspension, intravenous solution, oral concentrate, oral liquid, oral tablet</i></p><h3>General</h3><p>The most commonly occurring side effects have included alteration in glucose tolerance, behavioral and mood changes, increased appetite, and weight gain; the incidence generally correlates with dosage, timing of administration, and duration of treatment.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>A wide range of psychiatric reactions including affective disorders (e.g., irritable, euphoric, depressed, labile mood, and suicidal ideation) psychotic reactions (e.g., mania, delusions, hallucinations, aggravation of schizophrenia), behavioral disturbances, irritability, anxiety, sleep disturbances and cognitive dysfunction (e.g., confusion, amnesia) have been reported.  These reactions have been reported in adults and children.  In adults, the occurrence of severe reactions has been estimated to be about 5% to 6%.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Depression, affective disorders, anxiety, emotional instability, euphoria, insomnia, mood swings, personality changes, psychic disorders, confusional states, anxiety, abnormal behavior, irritability, aggravated schizophrenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Convulsions, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, benign intracranial hypertension, neuropathy<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Abdominal distention, nausea, pancreatitis, peptic ulcer, perforation of the small and large intestine, ulcerative esophagitis, gastric hemorrhage, vomiting, abdominal pain, diarrhea, dyspepsia, nausea, flatulence<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactoid reaction, anaphylaxis, angioedema<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Cushingoid state, hirsutism, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery, or illness), moon face<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Decreased carbohydrate and glucose tolerance, hyperglycemia, glycosuria, manifestations of latent diabetes, hypokalemic alkalosis, potassium loss, sodium retention, increased appetite, negative nitrogen balance due to protein catabolism, weight gain, metabolic acidosis, hypercholesterolemia, hypertriglyceridemia, dyslipidemia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, blindness, chorioretinopathy, worsening of symptoms associated with corneal ulcers, retinopathy of prematurity, blurred vision<sup>[Ref]</sup></p><p>Rare instances of blindness have been associated with corticosteroid intralesional therapy around the face and head.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis, edema<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Corticosteroids can cause a dose-dependent inhibition of growth in infancy, childhood, and adolescence due to it causing early closure of the epiphyses, which may be irreversible.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Suppression of growth in pediatric patients, aseptic necrosis of femoral and humeral heads, calcinosis, Charcot-like atrophy, loss of muscle mass, muscle weakness, steroid myopathy.  osteoporosis, pathologic fracture of long bones, postinjection flare, tendon rupture, particularly of the Achilles tendon, vertebral compression fractures, myalgia, muscle atrophy, osteonecrosis, neuropathic arthralgia, growth retardation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Acne, allergic dermatitis, dry scaly skin, ecchymosis, hirsutism, petechiae, erythema, hyperpigmentation, hypopigmentation, impaired wound healing, increased sweating, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria, hypertrichosis, angioedema, skin atrophy, hyperhidrosis, pruritus, burning or tingling especially in the perineal area (after IV injection), telangiectasia, pigment disorders<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leucocytosis, lymphopenia, eosinopenia, polycythemia, abnormal coagulation, polymorphonuclear leukocytosis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Menstrual irregularities, amenorrhea, increased or decreased motility and number of spermatozoa, increased urine calcium<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hepatomegaly, elevation in liver enzymes<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Opportunistic infection, exacerbation of latent infections, decreased resistance to infection, immunosuppression, candidiasis, chicken pox (varicella)</p><h3>Other</h3><p><b>Frequency not reported</b>: Vertigo, abnormal fat deposits, malaise, sterile abscess, impaired healing, fatigue, malaise</p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Hiccups, pulmonary edema</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Dexamethasone (dexamethasone)." Par Pharmaceutical Inc (formerly Qualitest Pharmaceuticals Inc), Huntsville, AL. </p><p id="ref_3">3. "Product Information. Dexamethasone Sodium Phosphate (dexamethasone)." West-Ward Pharmaceutical Corporation, Eatontown, NJ. </p><p id="ref_4">4. "Product Information. Decadron (dexamethasone)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_5">5. Sechi GP, Piras MR, Demurtas A, Tanca S, Rosati G "Dexamethasone-induced schizoaffective-like state in multiple sclerosis: prophylaxis and treatment with carbamazepine." Clin Neuropharmacol 10 (1987): 453-7</p><p id="ref_6">6. Carroll BJ, Schroeder K, Mukhopadhyay S, Greden JF, Feinberg M, Ritchie J, Tarika J "Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression." J Clin Endocrinol Metab 51 (1980): 433-7</p><p id="ref_7">7. Kanwar AJ, Kaur S, Dhar S, Ghosh S "Hiccup--a side-effect of pulse therapy." Dermatology 187 (1993): 279</p><p id="ref_8">8. Jaime Vazquez J "Persistent hiccup as a side-effect of dexamethasone treatment." Hum Exp Toxicol 12 (1993): 52</p><p id="ref_9">9. Fadul CE, Lemann W, Thaler HT, Posner JB "Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease." Neurology 38 (1988): 348-52</p><p id="ref_10">10. McDonnell M, Evans N "Upper and lower gastrointestinal complications with dexamethasone despite H2 antagonists." J Paediatr Child Health 31 (1995): 152-4</p><p id="ref_11">11. Whitmore SE "Dexamethasone injection-induced generalized dermatitis." Br J Dermatol 131 (1994): 296-7</p><p id="ref_12">12. Ludvik B, Clodi M, Kautzky-Willer A, Capek M, Hartter E, Pacini G, Prager R "Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans." Diabetologia 36 (1993): 84-7</p><p id="ref_13">13. New MI, Peterson RE, Saenger P, Levine LS "Evidence for an unidentified ACTH-induced steroid hormone causing hypertension." J Clin Endocrinol Metab 43 (1976): 1283-93</p><p id="ref_14">14. Tsoi WW "Cushing's syndrome caused by analgesic/dexamethasone preparation." Ann Pharmacother 28 (1994): 1411</p><p id="ref_15">15. Spenney JG, Eure CA, Kreisberg RA "Hyperglycemic, hyperosmolar, nonketoacidotic diabetes. A complication of steroid and immunosupressive therapy." Diabetes 18 (1969): 107-10</p><p id="ref_16">16. Godel V, Regenbogen L, Stein R "On the mechanism of corticosteroid-induced ocular hypertension." Ann Ophthalmol 10 (1978): 191-6</p><p id="ref_17">17. Bluming AZ, Zeegen P "Cataracts induced by intermittent Decadron used as an antiemetic." J Clin Oncol 4 (1986): 221-3</p><p id="ref_18">18. Kobayashi Y, Akaishi K, Nishio T, Kobayashi Y, Kimura Y "Posterior subcapsular cataract in nephrotic children receiving steroid therapy." Am J Dis Child 128 (1974): 671-3</p><p id="ref_19">19. Francois J "Corticosteroid glaucoma." Ann Ophthalmol 9 (1977): 1075-80</p><p id="ref_20">20. Schmidt GB, Meier MA, Sadove MS "Sudden appearance of cardiac arrhythmias after dexamethasone." JAMA 221 (1972): 1402-4</p><p id="ref_21">21. Rao G, Zikria EA, Miller WH, Samadani SR, Ford WB "Cardiac arrhythmias after dexamethasone." JAMA 222 (1972): 1185</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Can I use expired neomycin and polymyxin b sulfates, dexamethasone ophthalmic?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about HiDex (dexamethasone)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: glucocorticoids</li>
<li>FDA Alerts (7)</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Decadron, Dexamethasone Intensol, Dexasone, Baycadron, ... +8 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Allergic Rhinitis</li>
<li>Ankylosing Spondylitis</li>
<li>Aspiration Pneumonia</li>
<li>Asthma, acute</li>
<li data-more-config-id="list-data-resources-conditions">... +33 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dexamethasone: compounding powder, inhalation aerosol with adapter, injectable solution, injectable suspension, intravenous solution, oral concentrate, oral liquid, oral tablet</i></p><h3>General</h3><p>The most commonly occurring side effects have included alteration in glucose tolerance, behavioral and mood changes, increased appetite, and weight gain; the incidence generally correlates with dosage, timing of administration, and duration of treatment.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>A wide range of psychiatric reactions including affective disorders (e.g., irritable, euphoric, depressed, labile mood, and suicidal ideation) psychotic reactions (e.g., mania, delusions, hallucinations, aggravation of schizophrenia), behavioral disturbances, irritability, anxiety, sleep disturbances and cognitive dysfunction (e.g., confusion, amnesia) have been reported.  These reactions have been reported in adults and children.  In adults, the occurrence of severe reactions has been estimated to be about 5% to 6%.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Depression, affective disorders, anxiety, emotional instability, euphoria, insomnia, mood swings, personality changes, psychic disorders, confusional states, anxiety, abnormal behavior, irritability, aggravated schizophrenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Convulsions, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, benign intracranial hypertension, neuropathy<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Abdominal distention, nausea, pancreatitis, peptic ulcer, perforation of the small and large intestine, ulcerative esophagitis, gastric hemorrhage, vomiting, abdominal pain, diarrhea, dyspepsia, nausea, flatulence<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactoid reaction, anaphylaxis, angioedema<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Cushingoid state, hirsutism, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery, or illness), moon face<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Decreased carbohydrate and glucose tolerance, hyperglycemia, glycosuria, manifestations of latent diabetes, hypokalemic alkalosis, potassium loss, sodium retention, increased appetite, negative nitrogen balance due to protein catabolism, weight gain, metabolic acidosis, hypercholesterolemia, hypertriglyceridemia, dyslipidemia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, blindness, chorioretinopathy, worsening of symptoms associated with corneal ulcers, retinopathy of prematurity, blurred vision<sup>[Ref]</sup></p><p>Rare instances of blindness have been associated with corticosteroid intralesional therapy around the face and head.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis, edema<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Corticosteroids can cause a dose-dependent inhibition of growth in infancy, childhood, and adolescence due to it causing early closure of the epiphyses, which may be irreversible.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Suppression of growth in pediatric patients, aseptic necrosis of femoral and humeral heads, calcinosis, Charcot-like atrophy, loss of muscle mass, muscle weakness, steroid myopathy.  osteoporosis, pathologic fracture of long bones, postinjection flare, tendon rupture, particularly of the Achilles tendon, vertebral compression fractures, myalgia, muscle atrophy, osteonecrosis, neuropathic arthralgia, growth retardation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Acne, allergic dermatitis, dry scaly skin, ecchymosis, hirsutism, petechiae, erythema, hyperpigmentation, hypopigmentation, impaired wound healing, increased sweating, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria, hypertrichosis, angioedema, skin atrophy, hyperhidrosis, pruritus, burning or tingling especially in the perineal area (after IV injection), telangiectasia, pigment disorders<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leucocytosis, lymphopenia, eosinopenia, polycythemia, abnormal coagulation, polymorphonuclear leukocytosis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Menstrual irregularities, amenorrhea, increased or decreased motility and number of spermatozoa, increased urine calcium<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hepatomegaly, elevation in liver enzymes<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Opportunistic infection, exacerbation of latent infections, decreased resistance to infection, immunosuppression, candidiasis, chicken pox (varicella)</p><h3>Other</h3><p><b>Frequency not reported</b>: Vertigo, abnormal fat deposits, malaise, sterile abscess, impaired healing, fatigue, malaise</p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Hiccups, pulmonary edema</p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Dexamethasone (dexamethasone)." Par Pharmaceutical Inc (formerly Qualitest Pharmaceuticals Inc), Huntsville, AL. </p><p id="ref_3">3. "Product Information. Dexamethasone Sodium Phosphate (dexamethasone)." West-Ward Pharmaceutical Corporation, Eatontown, NJ. </p><p id="ref_4">4. "Product Information. Decadron (dexamethasone)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_5">5. Sechi GP, Piras MR, Demurtas A, Tanca S, Rosati G "Dexamethasone-induced schizoaffective-like state in multiple sclerosis: prophylaxis and treatment with carbamazepine." Clin Neuropharmacol 10 (1987): 453-7</p><p id="ref_6">6. Carroll BJ, Schroeder K, Mukhopadhyay S, Greden JF, Feinberg M, Ritchie J, Tarika J "Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression." J Clin Endocrinol Metab 51 (1980): 433-7</p><p id="ref_7">7. Kanwar AJ, Kaur S, Dhar S, Ghosh S "Hiccup--a side-effect of pulse therapy." Dermatology 187 (1993): 279</p><p id="ref_8">8. Jaime Vazquez J "Persistent hiccup as a side-effect of dexamethasone treatment." Hum Exp Toxicol 12 (1993): 52</p><p id="ref_9">9. Fadul CE, Lemann W, Thaler HT, Posner JB "Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease." Neurology 38 (1988): 348-52</p><p id="ref_10">10. McDonnell M, Evans N "Upper and lower gastrointestinal complications with dexamethasone despite H2 antagonists." J Paediatr Child Health 31 (1995): 152-4</p><p id="ref_11">11. Whitmore SE "Dexamethasone injection-induced generalized dermatitis." Br J Dermatol 131 (1994): 296-7</p><p id="ref_12">12. Ludvik B, Clodi M, Kautzky-Willer A, Capek M, Hartter E, Pacini G, Prager R "Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans." Diabetologia 36 (1993): 84-7</p><p id="ref_13">13. New MI, Peterson RE, Saenger P, Levine LS "Evidence for an unidentified ACTH-induced steroid hormone causing hypertension." J Clin Endocrinol Metab 43 (1976): 1283-93</p><p id="ref_14">14. Tsoi WW "Cushing's syndrome caused by analgesic/dexamethasone preparation." Ann Pharmacother 28 (1994): 1411</p><p id="ref_15">15. Spenney JG, Eure CA, Kreisberg RA "Hyperglycemic, hyperosmolar, nonketoacidotic diabetes. A complication of steroid and immunosupressive therapy." Diabetes 18 (1969): 107-10</p><p id="ref_16">16. Godel V, Regenbogen L, Stein R "On the mechanism of corticosteroid-induced ocular hypertension." Ann Ophthalmol 10 (1978): 191-6</p><p id="ref_17">17. Bluming AZ, Zeegen P "Cataracts induced by intermittent Decadron used as an antiemetic." J Clin Oncol 4 (1986): 221-3</p><p id="ref_18">18. Kobayashi Y, Akaishi K, Nishio T, Kobayashi Y, Kimura Y "Posterior subcapsular cataract in nephrotic children receiving steroid therapy." Am J Dis Child 128 (1974): 671-3</p><p id="ref_19">19. Francois J "Corticosteroid glaucoma." Ann Ophthalmol 9 (1977): 1075-80</p><p id="ref_20">20. Schmidt GB, Meier MA, Sadove MS "Sudden appearance of cardiac arrhythmias after dexamethasone." JAMA 221 (1972): 1402-4</p><p id="ref_21">21. Rao G, Zikria EA, Miller WH, Samadani SR, Ford WB "Cardiac arrhythmias after dexamethasone." JAMA 222 (1972): 1185</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Can I use expired neomycin and polymyxin b sulfates, dexamethasone ophthalmic?</li>
</ul><h2>More about HiDex (dexamethasone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: glucocorticoids</li>
<li>FDA Alerts (7)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Allergic Rhinitis</li>
<li>Ankylosing Spondylitis</li>
<li>Aspiration Pneumonia</li>
<li>Asthma, acute</li>
<li data-more-config-id="list-data-resources-conditions">... +33 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>